Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ore Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (41)	5/28/2010 10:56:41 PM
From: tuck	Read Replies (1) \| Respond to of 50

Hey, MIke, "Don't know what the p stands for, puny?" You've been around biotech too long not to know, so you're just joking, right? If not . . . In drug development, p-values are used to determine the outcome of a drug study. More here: en.wikipedia.org FDA seems to have arbitrarily set a p value of 0.05 for success. Meaning there is a 95% chance that the observed effect on the endpoint in question is from the drug. Or a 5% chance that is it isn't from the drug. Cheers, Tuck